학술논문

SAFETY AND TOLERABILITY OF LIVER-DERIVED STEM CELLS (HEPASTEM (TM)) INFUSED IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) OR ACUTE DECOMPENSATION (AD) AT RISK OF DEVELOPING ACLF: A EUROPEAN PHASE I/IIa OPEN-LABELLED STUDY
Document Type
Journal
Source
HEPATOLOGY; OCT 2019, 70 p71A-p72A, 2p. Supplement: 1
Subject
Language
English
ISSN
15273350